The pathogenesis of Kawasaki disease and superantigens

Japanese Journal of Infectious Diseases

Volumn 52, Issue 4, 1999, Pages 141-145

  Uchiyama, Takehiko ^a   Kato, Hidehito ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD11 ANTIGEN; CD18 ANTIGEN; INTERLEUKIN 2 RECEPTOR; SUPERANTIGEN;

BACTERIAL INFECTION; CORONARY ARTERY ANEURYSM; HUMAN; IMMUNOPATHOLOGY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; PATHOGENESIS; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; YERSINIA PSEUDOTUBERCULOSIS;

BACTERIAL TOXINS; CHILD, PRESCHOOL; ENTEROTOXINS; HUMANS; INFANT; MODELS, IMMUNOLOGICAL; MUCOCUTANEOUS LYMPH NODE SYNDROME; SUPERANTIGENS; T-LYMPHOCYTES; YERSINIA PSEUDOTUBERCULOSIS;

EID: 0032699084     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Kawasaki, T., Kosaka, F., Osawa, S., Shigematsu, I. and Yanagawa, H. (1974): A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics, 54, 271-276.
2. Leung, D. Y. M. (1990): Immunologic aspects of Kawasaki syndrome. J. Rheumatol., Suppl. 24, 15-17.
3. Kato, H., Akagi, T., Sugimura, T., Sato, N., Kazue, T., Hashino, K., Nishiyori, A. and Sakaguchi, M. (1995): Kawasaki disease. Coron. Artery Dis., 6, 194-206.
4. Abe, J., Kotzin, B.L., Jujo, K., Melish, M. E., Glode, M. P., Kohsaka, T. and Leung, D. Y. M. (1992): Selective expansion of T-cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc. Natl. Acad. Sci. USA, 89, 4066-4070.
5. Abe, J., Kotzin, B. L., Meissner, C., Melish, M. E., Takahashi, M., Fulton, D., Romagne, F., Malissen, B. and Leung, D. Y. M. (1993): Characterization of T cell repertoire changes in acute Kawasaki disease. J. Exp. Med., 177, 791-796.
6. Furukawa, S., Matsubara, T., Jujoh, K., Yone, K., Sugawara, T., Sasai, K., Kato, H. and Yabuta, K. (1988): Peripheral blood monocytes/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin. Immunol. Immunopathol., 48, 247-251.
7. Furukawa, S., Matsubara, T., Motohashi, T., Nakachi, S., Sasai, K. and Yabuta, K. (1990): Expression of Fc ε R2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease. Clin. Immunol. Immunopathol., 56, 280-286.
8. Matsubara, T., Mayumi, K. and Furukawa, S. (1997): Immune responses in Kawasaki disease. Jpn. J. Pediatr., 50, 27-34.
9. Fujiwara, H. and Hamashima, Y. (1978): Pathology of the heart in Kawasaki's disease. Pediatrics, 61, 100-107.
10. Hirose, S. and Hamashima, Y. (1978): Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. Eur. J. Pediatr., 129, 17-27.
11. Lang, B.A., Silverman, E. D., Laxer, R. M., Rose, V., Nelson, D. L. and Rubin, L.A. (1990): Serum-soluble interleukin-2 receptor level in Kawasaki disease. J. Pediatr., 116, 592-596.
12. Terai, M., Kohno, Y, Niwa, K., Toba, T., Sakurai, N. and Nakajima, H. (1987): Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease. Am. J. Cardiol., 60, 555-559.
13. Furukawa, S., Matsubara, T., Tsuji, K., Okumura, K. and Yabuta, K. (1993): Transient depletion of T cells with bright CD11a/CD18 expression from peripheral circulation during acute Kawasaki disease. Scand. J. Immunol., 37, 377-380.
14. Jason, J., Gregg, L., Han, A., Hu, A., Inge, K. L., Eick, A., Tham, I. and Campbell, R. (1997): Immunoregulatory changes in Kawasaki disease. Clin. Immunol. Immunopathol., 84, 296-306.
15. White, J., Herman, A., Pullen, A. M., Kubo, R., Kappler, J. W. and Marrack, P. (1989): The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell, 56, 27-35.
16. Uchiyama, T., Yan, X-J., Imanishi, K. and Yagi, J. (1994): Bacterial superantigens-mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol. Immunol., 38, 245-256.
17. Kotzin, B., Leung, D. Y. M., Kappler, J. and Marrack, P. (1993): Superantigens and their potential role in human disease. Adv. Immunol., 54, 99-166.
18. Uchiyama, T., Kamagata, Y., Yan, X-J., Kohno, M., Yoshioka, M., Fujikawa, H., Igarashi, H., Okubo, M., Awano, F., Saito-Taki, T. and Nakano, M. (1987): Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin-2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin. Clin. Exp. Immunol., 68, 638-647.
19. Uchiyama, T., Imanishi, K., Saito, S., Araake, M., Yan, X-J., Fujikawa, H., Igarashi, H., Kato, H., Obata, F., Kashiwagi, N. and Inoko, H. (1989): Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules. Eur. J. Immunol., 19, 1803-1809.
20. Uchiyama, T., Tadakuma, T., Imanishi, K., Araake, M., Saito, S., Yan, X-J., Fujikawa, H., Igarashi, H. and Yamaura, N. (1989): Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules. J. Immunol., 143, 3175-3182.
21. Kuroda, K., Yagi, J., Imanishi, K., Yan, X-J., Li, X-Y., Fujimaki, W., Kato, H., Miyoshi-Akiyama, T., Kumazawa, Y., Abe, H. and Uchiyama, T. (1996): Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen. J. Immunol., 157, 1422-1431.
22. Choi, Y., Lafferty, J. A., Clements, J. R., Todd, J. K., Gelfand, E. W., Kappler, J., Marrack, P. and Kotzin, B. L. (1990): Selective expansion of T cells expressing Vβ32 in toxic shock syndrome. J. Exp. Med., 172, 981-984.
23. Takahashi, N., Nishida, H., Kato, H., Imanishi, K., Sakata, Y. and Uchiyama, T. (1998): Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet, 351, 1614-1619.
24. Abe, J., Onimaru, M., Matsumoto, S., Noma, S., Baba, K., Ito, Y., Kohsaka, T., and Takeda, T. (1997): Clinical role for a superantigen in Yersinia pseudotuberculosis infection. J. Clin. Invest., 99, 1823-1830.
25. Takahashi, N., Nishida, H., Ino, M., Sakata, Y., Sakuma, I. and Takeda, Y. (1995): A new exanthematous disease in newborn infants. Acta Neonatal. Jpn., 31, 371-377.
26. + T cells in the small intestinal mucosa in Kawasaki disease. Pediatr. Res., 39, 264-266.
27. Jason, J., Montana, E., Donald, J. F., Seidman, M., Inge, K. L. and Campbell, R. (1998): Kawasaki Disease and the T-cell antigen receptor. Hum. Immunol., 59, 29-38.
28. Sakaguchi, M., Kato, H., Nishiyori, A., Sagawa, K. and Itoh, K. (1995): Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2-or V beta 8-CD4+ T helper cells. Clin. Exp. Immunol., 99, 276-282.
29. Pietra, B. A., Inocencio, J. D., Giannini, E. H. and Hirsch, R. (1994): TCR Vβ family repertoire and T cell activation markers in Kawasaki disease. J. Immunol., 153, 1881-1888.
30. Choi, I-H., Chwae, Y-J., Shim, W-S., Kim, D-S., Kwon, D-H., Kim, J-D. and Kim, S-J. (1997): Clonal expansion of CD8+ T cells in Kawasaki disease. J. Immunol., 159, 481-486.
31. Leung, D. Y. M., Meissner, H. C., Fulton, D. R., Murray, D. L., Kotzin, B. L. and Schlievert, P.M. (1993): Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet, 342, 1385-1388.
32. Nishiyori, A., Sakaguchi, M., Kato, H., Igarashi, H. and Miwa, K. (1994): Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet, 343, 299-300.
33. Curtis, N., Chan, B. and Levin, M. (1994): Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet, 343, 299.
34. Terai, M., Miwa, K., Williams, T., Kabat, W., Fukuyama, M., Okajima, Y., Igarashi, H. and Shulman, S.T. (1995): The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J. Infect. Dis., 172, 558-561.
35. Ueshiba, H., Kato, H., Miyoshi-Akiyama, T., Tsubokura, M., Nagano, T., Kaneko, S. and Uchiyama, T. (1998): Analysis of the superantigen-producing ability of Yersinia pseudotuberculosis strains of various serotypes isolated from patients with systemic or gastroenteric infections, wildlife animals and natural environments. Zentralbl. Bakteriol., 288, 277-292.
36. Sato, K., Ouchi, K. and Taki, M. (1983): Yersinia pseudotuberculosis infection in children, resembling Izumi fever and Kawasaki syndrome. Pediatr. Infect. Dis., 2: 123-126.
37. Baba, K., Yoshimitsu, H., Kameyama, J., Mitsudo, K. and Tanaka, M. (1985): Three cases with coronary aneurysms and elevated antibody-titers of Yersinia pseudotuberculosis. IGAKU NO AYUMI, 134, 271-272 (in Japanese).
38. Fukumoto, Y., Kaneko, K., Yamazaki, Y., Abe, H., Awano, H., Masaoka, J., Aoyama, K. and Toyama, M. (1998): Mass-infection of Yersinia pseudotuberculosis 4B in Shisui, Chiba. J. Jpn. Assoc. Infect. Dis., 61, 772-782 (in Japanese).
39. Konishi, N., Baba, K., Abe, J., Maruko, T., Waki, K., Takeda, T. and Tanaka, M. (1997): A case of Kawasaki disease with coronary artery aneurysmus documenting Yersinia pseudotuberculosis infection. Acta Paediatr., 86, 661-664.
40. Uchiyama, T., Miyoshi-Akiyama, T., Kato, H., Fujimaki, W., Imanishi, K. and Yan, X-J. (1993): Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J. Immunol., 151, 4407-4413.
41. Abe, J., Takeda, T., Watanabe, H., Nakao, N., Kobayashi, N., Leung, D. Y. M. and Kohsaka, T. (1993). Evidence for superantigen production by Yersinia pseudotuberculosis. J. Immunol., 151, 4183-4188.
42. Miyoshi-Akiyama, T., Abe, A., Kato, H., Kawahara, K., Narimatsu, H. and Uchiyama, T. (1995): DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM. J. Immunol., 154, 5228-5234.